MARATTO

article · Reumatología Clínica (English Edition)

CXCL10 as a biomarker of interstitial lung disease in patients with rheumatoid arthritis

20245 citationsAssiut University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Rheumatoid Arthritis Research and Therapies
  • Sarcoidosis and Beryllium Toxicity Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.reumae.2023.12.005

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.